Gene vaccination: plasmid DNA is more than just a blueprint.

Abstract Despite the popularity of using plasmid DNA for vaccination, it is only recently that the basic mechanisms that drive the immune response to the encoded antigen have begun to unfold. Here, Helen Tighe and colleagues outline the characteristics of the immune response induced by gene vaccination and describe the multifaceted properties of DNA in initiating and determining the process.

[1]  Y. Barenholz,et al.  Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. , 1995, Journal of immunology.

[2]  M. Bennett,et al.  Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis. , 1997, Journal of immunology.

[3]  M. Provinciali,et al.  Autoantibody to p185erbB2/neu oncoprotein by vaccination with xenogenic DNA , 1997, Cancer Immunology, Immunotherapy.

[4]  C. Snapper,et al.  Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice , 1991, The Journal of experimental medicine.

[5]  D. Doolan,et al.  Nucleic Acid Malaria Vaccines , 1995 .

[6]  J. Wands,et al.  Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. , 1997, Journal of immunology.

[7]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[8]  E. Kuramoto,et al.  In vitro Augmentation of Natural Killer Cell Activity and Production of Interferon‐α/β and ‐γ with Deoxyribonucleic Acid Fraction from Mycobacterium bovis BCG , 1988, Japanese journal of cancer research : Gann.

[9]  R A Houghten,et al.  Induction of neonatal tolerance by plasmid DNA vaccination of mice. , 1996, The Journal of clinical investigation.

[10]  E. Kuramoto,et al.  Antitumor Activity of Synthetic Oligonucleotides with Sequences from cDNA Encoding Proteins of Mycobacterium bovis BCG , 1992, Japanese journal of cancer research : Gann.

[11]  H. Davis,et al.  DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. , 1996, Vaccine.

[12]  J. Monaco,et al.  The genetics of proteasomes and antigen processing. , 1995, Annual review of genetics.

[13]  J. Reimann,et al.  DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors. , 1996, Journal of immunology.

[14]  R. Webster,et al.  Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. , 1994, Vaccine.

[15]  D. Pisetsky.  Immune activation by bacterial DNA: a new genetic code. , 1996, Immunity.

[16]  I. Cohen,et al.  Suppressive vaccination with DNA encoding a variable region gene of the T–cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity , 1996, Nature Medicine.

[17]  E. Kuramoto,et al.  Synthetic Oligonucleotides with Particular Base Sequences from the cDNA Encoding Proteins of Mycobacterium bovis BCG Induce Interferons and Activate Natural Killer Cells , 1992, Microbiology and immunology.

[18]  H. Ploegh,et al.  Intracellular transport of MHC class II molecules. , 1992, Immunology today.

[19]  M. Kovacsovics-Bankowski,et al.  A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules , 1995, Science.

[20]  R. Hohlfeld,et al.  The immunobiology of muscle. , 1994, Immunology today.

[21]  K. Heeg,et al.  Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway. , 1995, Immunology.

[22]  H. Okamura,et al.  Cloning of a new cytokine that induces IFN-γ production by T cells , 1995, Nature.

[23]  G. Trinchieri.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.

[24]  D. Pisetsky,et al.  Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. , 1991, Journal of immunology.

[25]  J. Fechner,et al.  Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle. , 1994, Journal of immunology.

[26]  J. Ulmer,et al.  Heterologous protection against influenza by injection of DNA encoding a viral protein. , 1993, Science.

[27]  C. Harding,et al.  Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. , 1994, Journal of immunology.

[28]  Donna L. Montgomery,et al.  Immunogenicity and protective efficacy of a tuberculosis DNA vaccine , 1996, Nature Medicine.

[29]  HL Davis,et al.  Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA , 1997, Gene Therapy.

[30]  M. Yokoyama,et al.  DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection , 1995, Journal of virology.

[31]  J. Ulmer,et al.  Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cells , 1996, Immunology.

[32]  A. Krieg,et al.  Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. , 1996, Journal of immunology.

[33]  Y. Fujisawa,et al.  Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. , 1984, Journal of the National Cancer Institute.

[34]  A. Bird.  CpG-rich islands and the function of DNA methylation , 1986, Nature.

[35]  G. Acsadi,et al.  Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. , 1992, Human molecular genetics.

[36]  H. Davis,et al.  DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. , 1993, Human molecular genetics.

[37]  D. Pisetsky,et al.  Bacterial DNA Induces Murine Interferon-γ Production by Stimulation of Interleukin-12 and Tumor Necrosis Factor-α , 1996 .

[38]  Simon C Watkins,et al.  DNA–based immunization by in vivo transfection of dendritic cells , 1996, Nature Medicine.

[39]  T. Mosmann,et al.  Functional diversity of T lymphocytes due to secretion of different cytokine patterns , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  D. Richman,et al.  Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants , 1997, Nature Medicine.

[41]  L. Babiuk,et al.  Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA , 1993, Journal of virology.

[42]  D. Weiner,et al.  Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination , 1997, Nature Medicine.

[43]  D. Pisetsky.  DNA and the Immune System , 1997, Annals of Internal Medicine.

[44]  F. Liew,et al.  Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. , 1995, Immunology.

[45]  J. Reimann,et al.  Targeting an anti-viral CD8+ T cell response to a growing tumor facilitates its rejection , 1997, Cancer Immunology, Immunotherapy.

[46]  R. Germain,et al.  Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis , 1995, The Journal of experimental medicine.

[47]  M. Croft,et al.  A direct role for IFN-gamma in regulation of Th1 cell development. , 1996, Journal of immunology.

[48]  J. Shiver,et al.  Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. , 1993, DNA and cell biology.

[49]  R. Schwartz,et al.  Antigen presentation by chemically modified splenocytes induces antigen- specific T cell unresponsiveness in vitro and in vivo , 1987, The Journal of experimental medicine.

[50]  A. Sing,et al.  Interferon beta, a cofactor in the interferon gamma production induced by gram-negative bacteria in mice , 1995, The Journal of experimental medicine.

[51]  D. Carson,et al.  Costimulation provided by DNA immunization enhances antitumor immunity. , 1997, Journal of immunology.

[52]  H. Fujita,et al.  Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin , 1983, The Journal of experimental medicine.

[53]  B. Rouse,et al.  Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. , 1995, Journal of immunology.

[54]  Z. Xiang,et al.  Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. , 1994, Virology.

[55]  C. Heusser,et al.  Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells , 1993, The Journal of experimental medicine.

[56]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[57]  R. Schwartz.  Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy , 1992, Cell.

[58]  D. Klinman,et al.  Contribution of CpG motifs to the immunogenicity of DNA vaccines. , 1997, Journal of immunology.

[59]  C. Leclerc,et al.  DNA‐Mediated Immunization to the Hepatitis B Surface Antigen , 1995, Annals of the New York Academy of Sciences.

[60]  M. Colston,et al.  Vaccination against tuberculosis by DNA injection , 1996, Nature Medicine.

[61]  R. Webster,et al.  Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. , 1997, Journal of immunology.

[62]  K. Rock,et al.  Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines , 1994, European journal of immunology.

[63]  J. Reimann,et al.  DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. , 1995, Human gene therapy.

[64]  R. Schwartz,et al.  Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. , 1987, Journal of immunology.

[65]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[66]  B. Rouse,et al.  DNA immunization of neonates induces immunity despite the presence of maternal antibody. , 1997, The Journal of clinical investigation.

[67]  B. Rouse,et al.  Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27. , 1995, Viral immunology.

[68]  M. de Carli,et al.  IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. , 1992, Journal of immunology.

[69]  E. Kuramoto,et al.  Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity. , 1992, Journal of immunology.

[70]  P. Srivastava,et al.  A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. , 1995, Science.

[71]  R. Welsh,et al.  Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. , 1995, Journal of immunology.

[72]  D. Tang,et al.  Genetic immunization is a simple method for eliciting an immune response , 1992, Nature.

[73]  H. Ploegh,et al.  Generation, translocation, and presentation of MHC class I-restricted peptides. , 1995, Annual review of biochemistry.

[74]  R. Levy,et al.  DNA immunization induces protective immunity against B–cell lymphoma , 1996, Nature Medicine.

[75]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[76]  E. Raz,et al.  Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization , 1996, Science.

[77]  J. Shiver,et al.  Cytotoxic T Lymphocyte and Helper T Cell Responses following HIV Polynucleotide Vaccination , 1995, Annals of the New York Academy of Sciences.

[78]  Z. Xiang,et al.  Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. , 1995, Immunity.

[79]  Z. Xiang,et al.  Immune response to neonatal genetic immunization. , 1997, Virology.

[80]  R. Schwartz,et al.  Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. , 1989, Annual review of immunology.

[81]  D. Lancki,et al.  Differential regulation of murine T lymphocyte subsets. , 1993, Annual review of immunology.

[82]  D. Pardoll,et al.  In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. , 1996, Immunity.

[83]  A. García-Sastre,et al.  DNA immunization of newborn mice with a plasmid-expressing nucleoprotein of influenza virus. , 1996, Viral immunology.

[84]  F. Annunziato,et al.  Polyinosinic acid: polycytidylic acid promotes T helper type 1‐specific immune responses by stimulating macrophage production of interferon‐α and interleukin‐12 , 1995, European journal of immunology.

[85]  E. Kuramoto,et al.  DNA from Bacteria, but Not from Vertebrates, Induces Interferons, Activates Natural Killer Cells and Inhibits Tumor Growth , 1992, Microbiology and immunology.

[86]  D. Fuller,et al.  A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. , 1994, AIDS research and human retroviruses.

[87]  T. Mosmann,et al.  The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.

[88]  R. Webster,et al.  Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. , 1993, DNA and cell biology.

[89]  H. Yamamoto,et al.  Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors. , 1985, Journal of the National Cancer Institute.

[90]  W. W. Nichols,et al.  Potential DNA Vaccine Integration into Host Cell Genome , 1995, Annals of the New York Academy of Sciences.

[91]  J. Ulmer,et al.  Protective Efficacy of Intramuscular Immunization with Naked DNA , 1995, Annals of the New York Academy of Sciences.

[92]  T. Tokunaga,et al.  In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG. , 1986, Japanese journal of cancer research : Gann.

[93]  Shau-ku Huang,et al.  Immunoprophylaxis of allergen–induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization , 1996, Nature Medicine.

[94]  J. Drazen,et al.  Sorting out the cytokines of asthma , 1996, The Journal of experimental medicine.

[95]  K. Rock,et al.  Antigen processing and presentation by the class I major histocompatibility complex. , 1996, Annual review of immunology.

[96]  V. Srikantan,et al.  DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. , 1993, DNA and cell biology.